• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Theradaptive Secures $26M in Series A Funding to Advance Targeted Regenerative Therapeutics

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 16, 2023 at 10:32: AM
via Theradaptive, a Frederick, MD-based biopharmaceutical company focused on targeted regenerative therapeutics, raised $26M in Series A funding.

The round brought the total funding to over $50M. The backers were not disclosed.

article source
 

<



Similar threads

cafead
Cercle secures $6M seed fundraise to advance women’s healthcare
Replies
0
Views
2
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Sangamo secures $50M upfront in neurodegenerative pact with Roche&#039;s Genentech
Replies
0
Views
65
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development
Replies
0
Views
22
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AI-focused Formation secures Sanofi-backed $372M series D to license more drugs
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J-backed Bright Peak secures $90m to advance immunoconjugate program
Replies
0
Views
10
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote